Sort
48,018 grants matching “immunotherapy”
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2016 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2017 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$372,870Garry P Nolan · Stanford University · U54 · FY2020 · CA
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$372,867Adam M Sonabend · Northwestern University At Chicago · R01 · FY2021 · NS
Stability and potency of LAP+FOXP3+Tregs as novel cell therapy for GVHD
$372,863Dat Quoc Tran · University Of Texas Hlth Sci Ctr Houston · R01 · FY2012 · HL
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$372,863Franck Housseau · Johns Hopkins University · R01 · FY2016 · CA
Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy
$372,861Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients with High-
$372,861Nai-Kong V Cheung · Sloan-Kettering Inst Can Research · R21 · FY2011 · CA
Human mast cells as a platform for new cancer immunotherapy strategies
$372,846Chris L Kepley · Liberty University, Inc. · R15 · FY2023 · CA
Tumor cell instrinsic DNA damage signaling to the immune response
$372,839Roger A Greenberg · University Of Pennsylvania · P01 · FY2025 · CA
HTS for the discovery of activators of NK cell cytotoxicity
$372,835David Wald · Case Western Reserve University · R01 · FY2023 · CA
Novel ways to prevent upper GT infection
$372,805Kathleen A. Kelly · University Of California Los Angeles · R01 · FY2014 · AI
Understanding the Mechanism of Mucosal Immunotherapy
$372,751Arvil Wesley Burks · Univ Of North Carolina Chapel Hill · R01 · FY2014 · AI
Mechanisms and consequences of iNKT cell anergy
$372,695Luc Van Kaer · Vanderbilt University · R01 · FY2010 · AI
Novel Biological Activities of Anti-Viral Antibody
$372,690University Of California Irvine · R01 · FY2004 · AI
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$372,669Ann Richmond · Vanderbilt University · R01 · FY2022 · CA
Understanding the Mechanism of Mucosal Immunotherapy
$372,651Arvil Wesley Burks · Univ Of North Carolina Chapel Hill · R01 · FY2015 · AI
Adenovirus as a Vector for Gene Therapy
$372,644Patrick Hearing · State University New York Stony Brook · R01 · FY2010 · AI
Monoclonal antibodies to inhibit Aspergillus germination
$372,563Marta L. Feldmesser · Albert Einstein College Of Medicine · R01 · FY2006 · AI
Role of cross-presentation by APCs in modulating graft-versus-leukemia responses
$372,559Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2008 · HL
Understanding the Mechanism of Mucosal Immunotherapy
$372,549Arvil Wesley Burks · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
Virulence and Immunity to Staphylcocci
$372,549Brigham And Women'S Hospital · R01 · FY2004 · AI
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma
$372,485Guisheng Song · University Of Minnesota · R01 · FY2022 · CA
MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma
$372,485Guisheng Song · University Of Minnesota · R01 · FY2025 · CA
CELLULAR AND MOLECULAR CHARACTERIZATION OF REGULATORY T CELL DEVELOPMENT
$372,438Chyi S Hsieh · Washington University · R01 · FY2011 · AI